Hypermobility syndromes
Download as PPTX, PDF9 likes3,464 views
This document provides information on several connective tissue disorders and hypermobility syndromes that can affect children, including Benign Joint Hypermobility Syndrome (BJHS), Ehlers-Danlos Syndromes (EDS), Marfan Syndrome, Loeys-Dietz Syndrome, and Stickler Syndrome. It describes the clinical features, diagnostic criteria, inheritance patterns, genetic causes, and multidisciplinary management of these conditions. Key points include that BJHS and the hypermobility type of EDS may exist on a spectrum, cardiovascular involvement is a major concern in Marfan Syndrome, Loeys-Dietz Syndrome involves severe arterial abnormalities, and Stickler Syndrome can affect the eyes, ears, skeleton
Hypermobility syndromes
- 1. Hypermobility syndromes Mohamed Ahmed Hefny, MD.
- 2. Benign joint hypermobility syndrome (BJHS) • Children with hypermobile joints by definition display a range of movement that is considered excessive, taking into consideration the age, gender and ethnic background of the individual. • 10–15 % of normal children have hypermobile joints and the term joint hypermobility syndrome (JHS) is reserved to the cases of joint hypermobility associated with symptoms with no other causes found for them. • JHS can be associated with hereditary CTD, and the term “Benign” is used in contrast to more serious and potentially complicated or life-threatening musculoskeletal syndromes such as some forms of Ehlers-Danlos syndrome (EDS), Marfan syndrome, and Loeys-Dietz syndrome. • The prevalence of JHS is unknown with precision, healthy schoolchildren, aged 8–13 years from the province of Padua, Italy, and found that BJHS occurred in the 13,2 % of the 289 children evaluated.
- 3. • Even if BJHS is very common, this condition is largely under-recognized by PC physicians and often poorly managed. • Symptoms frequently start in childhood and continue into adult life. The pathophysiology of benign joint hypermobility is unclear. • Hypermobility is more common in childhood and adolescence, in females, and in some ethnicities, and it tends to lessen during adulthood. • Still, polyarticular hypermobility may be present in up to 30 % of males and 40 % of females during early adulthood. • For the majority of individuals joint hypermobility may be of no consequence, and what brings a proportion of subjects to develop BJHS is not fully understood.
- 4. • BJHS seems to be transmitted by an autosomal pattern, and first-degree relatives with the disorders can be identified in many cases. Variable penetrance is generally observed. • With the exception of a minority of patients, who show a deficiency of tenascin X, no abnormality in collagen or related proteins has been identified as a cause for BJHS. • Joint pain is thought to be caused by excessive movement, increasing stress on joint surfaces, ligaments and adjacent structures. • Other factors may contribute to the development of the syndrome, such as poor proprioception, autonomic dysfunctions and fatigue secondary to poor sleep.
- 5. • Predominant presenting complaint is pain, widespread and debilitating. • Pain typically starts during or after activity • Affected sites are the LL’s after walking (for example walking to and from school). • Excess fatigue, handwriting difficulties or ‘clicking or cracking’ joints. • Occasionally episodes of joint swelling lasting hours to days, joint dislocations, or subluxations with spontaneous reduction are reported. • LBP is a common complaint • Heavy school bags are often an aggravating feature. • Chronic pain results in a reduced exercise tolerance and can negatively impact patients’ life.
- 6. • A significant proportion of subjects progressively quit sports and other physical activities. • BJHS has been considered to cause only musculoskeletal symptoms for many years, but there is now mounting evidence that many other extra- skeletal manifestations may occur. • This symptoms arise usually after the third decade of life, but have been described in adolescents, and may be due to connective tissue abnormalities, linking BJHS and other hereditary disorders of CT, namely EDS type III. • These include functional and anatomic GIT abnormalities (constipation, bloating, diarrhea, hiatal hernias), autonomic dysfunctions (postural tachycardia syndrome, palpitations, orthostatic intolerance, headache, fatigue) and skin abnormalities (easy bruising, striae).
- 7. • Some of these symptoms are overlapping with those observed in Juvenile Fibromyalgia (JFM), and indeed there are few reports describing high incidence of BJHS in children with JFM. • Furthermore, children who have both JFM and BJHS may exhibit lower tender points thresholds and a greater number of tender-points compared to children with JFM but no benign joint hypermobility. • The “Beighton score” is commonly used to diagnose hypermobility. • Hypermobility is present if 4/9 points are scored. But it may be better to consider a Beighton score of 5 or more positive.
- 8. The Beighton score has been incorporated into a more comprehensive set of criteria called the Brighton Criteria, which take into account the possible multisystemic nature of this condition. Although these criteria have not been formally validated in a pediatric population, they have been used in some studies on children with hypermobility.
- 11. • Acute pain episodes are commonly managed using taping, bracing or splinting or with NSAID’s as needed. • Physical therapy is of the outmost importance, and encouraging an active lifestyle may improve function and enhance QOL. • Strengthening exercises focused on muscles around hypermobile joints may help to enhance joint support throughout movement and reduce pain; closed chain exercises may enhance proprioceptive feedback and optimize muscle action. • Proprioception may be improved by coordination and balance exercises. • PT should also address cardio-respiratory, musculoskeletal and neurological aspects of movement with the aim to reduce deconditioning.
- 12. Ehlers-Danlos Syndromes (EDSs) • EDSs comprise a very heterogeneous group of heritable disorders of CT. • The increased flexibility and fragility of the soft connective tissues result in a wide range of changes in the skin, ligaments, joints, blood vessels and internal organs. • Villefranche classification recognizes six subtypes, according to clinical features, inheritance pattern and underlying molecular defects . • In the last few years, rarer phenotypes that do not fit in the Villefranche classification have been described. • Prevalence of EDS is estimated to be approximately one in 5000 births, with no racial predisposition.
- 13. • CT fragility follows abnormalities in the expression or structure of the fibrillar collagen types I, III and V, as well as enzymatic abnormalities in the post-translational modification and processing of these collagens. • Mutations in the COL5A1 and COL5A2 genes, encoding the α1- and the α2- chains of type V collagen, respectively, are found in approximately 50 % of individuals with the classic type of EDS. • Mutations in TNX-B, encoding for Tenascin X, in approximately 5 % of patients with the hypermobility type, while vascular EDS is caused by heterozygous mutations in the COL3A1 gene, encoding type III collagen
- 15. • The clinical spectrum of EDSs varies from mild skin and joint hyperlaxity to severe physical disability and life-threatening vascular complications. • The classic, hypermobility and vascular subtype of EDS are the most common, whereas the kyphoscoliosis, arthrochalasis and dermatosparaxis types are very rare conditions. • The diagnosis of the autosomal dominant (AD) classic subtype of EDS requires the presence of skin hyperextensibility, widened atrophic scars and joint hypermobility. • 3 major diagnostic criteria, next to a series of ‘minor’ diagnostic manifestations. Characteristic facial features include epicanthic folds, excess skin over the eyelids, presence of dilated scars on the forehead and vaulted palate. • Joint hypermobility is usually generalized and can vary in severity and with age.
- 18. Dermatosparaxis
- 19. • At birth, uni- or bilateral dislocation of the hip may be present. • Even if the hypermobility is asymptomatic, this condition can result in childhood in congenital club foot, pes planus and joint effusions. • In young adulthood the classic subtype can be complicated by repetitive subluxations and dislocations either spontaneously or after minimal trauma. • Patients usually report chronic and recurrent pain that is difficult to treat and premature osteoarthritis is a major concern. • One of the most typical features is the skin hyper-extensibility, which means that the skin stretches easily but snaps back after release. The skin is often smooth and velvety to the touch.
- 20. • For pediatric rheumatologists, a real diagnostic challenge is represented by the hypermobility subtype of EDS (EDS-HT), which is by far the most common subtype. • The genetic basis of EDS-Hybermobile is largely unknown and a reliable diagnostic test for this EDS subtype is lacking. • According to the Villefranche classification, the major diagnostic criteria are generalized joint hypermobility and presence of typical skin manifestations. • It is still a matter of debate if EDS-HT and BJHS really represents two different diseases or if they should be reviewed as a spectrum of a single entity, sharing common genetic bases and showing considerable variability in clinical presentation, between as well as within families.
- 21. • JH is typically limited to the small joints of the hands in the vascular subtype. This subtype has the worst prognosis because of a high rate of spontaneous arterial rupture usually in the third or the fourth decade of life. • Unlike other EDS types, the skin is not hyperextensible, but rather thin and translucent, showing a visible venous pattern over the chest, abdomen and extremities. • Excessive bruising is the most common sign and is often the presenting complaint, especially in children.
- 22. • Other early manifestations include premature rupture of the membranes, congenital clubfoot or congenital hip dislocation, inguinal hernia, and severe varicosities. The facial and cutaneous features may be very subtle or even absent. • If there is a strong clinical suspicion of vascular EDS, direct DNA analysis is mandatory, even in the absence of an abnormal biochemical abnormality.
- 23. The management of children with Ehlers-Danlos syndromes requires a multidisciplinary approach • Children are advised to avoid contact sports and to wear protective gear • Cutaneous stitches should be left in place twice as long as usual, and additional fixation of adjacent skin with adhesive tape can help to prevent stretching of the scar. • In children PT support is important. • Acetaminophen should be preferred over NSAIDs for joint pain. • Patients with mitral valve prolapse and regurgitation require antibiotic prophylaxis for bacterial endocarditis.
- 24. • A baseline echocardiogram before 10 years of age, with follow-up according to whether an abnormal measurement is found. • For the vascular and vascular-like types of EDS, invasive vascular procedures such as arteriography and catheterization should be avoided because of the risk for life-threatening vascular rupture. • Surgical interventions are generally avoided
- 25. Marfan Syndrome (MS) • MS is an hereditary autosomal dominant, multisystem disorder of connective tissue with extensive clinical variability. • It is a relatively common condition, with approximately 1 in 5000 people affected. • This disease demonstrates autosomal-dominant inheritance with high penetrance and marked inter- and intra-familial variability. • It is caused by defects in FBN1, the gene that codes for the protein fibrillin, although patients with mutations in other genes, including TGFBR1 and TGFBR2, have also been rarely reported. • Mutations in FBN1 are associated with a wide phenotypic spectrum ranging from classic features of Marfan syndrome presenting in childhood and early adulthood to severe neonatal presentation. • Advanced paternal age is a risk factor.
- 26. • Cardinal features involve the ocular, musculoskeletal, and cardiovascular systems. • Skeletal system involvement in MS is characterized by bony overgrowth. • Frequent findings are pectus excavatum, pectus carinatum, scoliosis or spondylolisthesis, calcaneal displacement, “protrusio acetabuli”, arachnodactyly, and pes planus. • Recently, Marfan patients have been reported to have reduced bone mass and muscle mass, compared to healthy controls. • All this skeletal abnormalities may account for the very high incidence of severe daily pain that Marfan patients report
- 29. • Joint laxity may be significant in young MS patients and can lead to ligament injury, dislocations, chronic joint pain and degenerative arthritis. • The facial features of Marfan syndrome include a long and narrow face with deeply set eyes (enophthalmos), downward slanting of the eyes, flat cheek bones (malar hypoplasia) and high arched palate. • Ectopia lentis is a cardinal feature of Marfan syndrome and an ophthalmologic examination is mandatory in suspected cases. • During early childhood, patients may occasionally present with isolated bilateral ectopia lentis. • Cardiovascular involvement is particularly worrisome because the progressive aorticroot dilatation can lead to acute dissection, aneurysms and sudden death. • Marfan syndrome continue to have high rates of cardiovascular disease and premature death.
- 30. • The diagnosis is clinical, according to the revised Ghent criteria. • These criteria however perform well in patients showing the typical phenotypes. • These criteria are not as useful in milder MS variants, when only isolated features are present. • In young children Marfan syndrome is not always recognizable, especially in the absence of a family history, because many of the more specific clinical features are age dependent (e.g., ectopia lentis, aortic dilation, dural ectasia, protrusio acetabuli). • For subjects suspected to have Marfan syndrome based on clinical grounds FBN1 testing should be considered. • A useful tool for risk stratification of suspected pediatric patients can be represented by the Kid-Short Marfan Score.
- 31. • Diagnosis and management require a multidisciplinary approach by geneticists, cardiologists, orthopedic surgeons and ophthalmologists with experience in this field. • Cardiovascular follow-up should include serial evaluation with electrocardiography and serial cardiac imaging, especially CT/MRI angiography. • Exercise restriction is wise and elective aortic-root replacement is sometimes needed. • Endocarditis prophylaxis is indicated in those with valvular defects. • Medical therapy with beta-blockers seems to be able to decrease aortic root enlargement, especially when started relatively early in the disease course, while the role of ACE inhibitors is still debated.
- 32. Loeys-Dietz syndrome (LDS) • LDS is a recently described rare autosomal dominant connective tissue disorder characterized by a severe and widespread arterial involvement since childhood. • Its exact incidence have not been established. • The disorder is most often caused by heterozygous mutations in TGF-β receptors TGFBR1 and TGFBR2. • The classification depends on the presence or absence of craniofacial features (hypertelorism, bifid uvula and cleft palate). Affected individuals show generalized arterial abnormalities, ascending aneurysms and rapidly progressive aortic aneurysm.
- 33. • Skeletal features in all types of LDS may show overlap with Marfan syndrome (i.e., pectus deformity, arachnodactyly, scoliosis, and pes planus) but height and proportions are typically within the normal range. • Joint hypermobility is also common. • A more specific finding is the association of arachnodactyly with advanced carpal bone ossification and joint hyperextension. • LDS diagnostic criteria have not been defined and confirmatory genetic testing is required.
- 35. • Management of LDS involves regular cardiology follow-up to establish the extent of vascular involvement, early surgical intervention, genetic counseling and monitoring in pregnancy. • There is a higher risk of dissection compared to Marfan syndrome, and early surgical correction may be crucial. • Aggressive medication regimens, with β- blockers and angiotensin receptor antagonists, is recommended as this treatment may halt disease progression and postpone surgical repair.
- 36. Stickler syndrome (SS) • SS is a multisystem connective tissue disorder that can affect the eye, craniofacies, inner ear, skeleton, and joints. • Stickler syndrome has been associated with mutations of COL2A1, which encodes for the alpha-1 chain of type II collagen, COL11A1 gene, which encodes for the alpha-1 chain of type XI collagen, and COLL11A2 gene. • Rarer autosomal recessive forms have been linked to mutation of the three genes encoding collagen IX: COL9A1- 2-3. • Variable phenotypic expression of Stickler syndrome occurs both within and among families.
- 37. • Based on the vitreous abnormalities Stickler syndrome is classified as Type 1 (“membranous”; characterized by a persistence of vestigial vitreous gel in the retrolental space) and the rare Type 2 (“beaded”, characterized by sparse and irregularly thickened bundles throughout the vitreous cavity). • A non-progressive myopia is common. Craniofacial findings may include a flat facial profile, telecanthus and epicanthal folds, micrognathia and cleft palate. • Hearing impairment, especially sensorineural deafness for high tones, is common but the overall sensorineural hearing loss in type I Stickler syndrome is typically mild and not significantly progressive. • The musculoskeletal features are early onset arthropathy, short stature and mild spondyloepiphyseal dysplasia. In children and adolescents joint hypermobility is seen and usually becomes less prominent with age.
- 38. • The diagnosis of Stickler syndrome is clinically based. At present, clinical diagnostic criteria have been proposed only for type 1 Stickler syndrome. • Type 1 individuals have the membranous type of vitreous abnormality. • The diagnosis of Stickler syndrome requires genetic analysis of the involved genes. • COL2A1 gene may be tested first in individuals with type 1 “membranous” vitreous abnormalities and milder hearing loss. • COL1A1 mutations can be frequently found in patients with craniofacial and joint manifestations as well as hearing loss but without ocular findings.
- 39. Thank You